Rogers Corporation 10-Q Summary
Reporting period: Three and nine months ended September 30, 2022; filed November 8, 2022. Rogers designs and manufactures engineered materials and components through its Advanced Electronics Solutions (AES), Elastomeric Material Solutions (EMS), and Other segments.
Financial Performance and Position
| Metric | Q3 2022 | Q3 2021 | 9M 2022 | 9M 2021 |
|---|---|---|---|---|
| Net sales | $247.2 million | $238.3 million | $747.5 million | $702.4 million |
| Gross margin | $78.1 million; 31.6% | $91.7 million; 38.5% | $250.0 million; 33.4% | $271.0 million; 38.6% |
| Operating income | $18.5 million; 7.5% | $33.8 million; 14.2% | $61.8 million; 8.3% | $106.7 million; 15.2% |
| Net income | $14.8 million | $25.1 million | $49.3 million | $85.0 million |
| Diluted EPS | $0.78 | $1.33 | $2.60 | $4.51 |
| Operating cash flow | Not separately provided | Not separately provided | $1.8 million | $106.1 million |
- Q3 sales increased 3.8%; nine-month sales increased 6.4%. EMS sales increased 13.3% in Q3 and 16.9% year to date, while AES sales declined 3.2% and 0.6%, respectively.
- Gross margin contracted substantially because of higher fixed overhead, unfavorable absorption, freight, duties and tariffs, lower productivity, product mix, yield issues, inventory reserves, and supply constraints.
- SG&A increased to $50.7 million in Q3 and $164.5 million for nine months, partly reflecting professional fees, retention awards, and a discretionary $6.5 million RESIP contribution associated with the terminated DuPont transaction.
- R&D increased to $9.1 million in Q3 and $25.5 million for nine months.
- The effective tax rate declined to 16.0% in Q3 and 20.5% for nine months, versus 26.4% and 25.7%, respectively, primarily because of lower accruals for uncertain tax positions.
Liquidity, Debt, and Cash Flow
- Cash and cash equivalents were $236.5 million at September 30, 2022, versus $232.3 million at December 31, 2021. Approximately $119.1 million was held by non-U.S. subsidiaries.
- Operating cash flow was only $1.8 million for the first nine months, down from $106.1 million, primarily reflecting higher inventories, accounts receivable, contract assets, and other working-capital needs.
- Capital expenditures were $87.0 million through September 30; management expected full-year 2022 capital spending of approximately $120 million to $130 million.
- Borrowings under the revolving credit facility increased to $290.0 million from $190.0 million at year-end. The facility has $450.0 million of capacity plus a $175.0 million accordion feature and matures March 31, 2024.
- The company stated that existing cash, expected operating cash flow, and available credit facilities should fund operations, planned capital expenditures, research and development, and debt service for at least the next 12 months.
- The credit agreement requires a total net leverage ratio of no more than 3.25 to 1.00 and interest coverage of at least 3.00 to 1.00. The company reported that its total net leverage ratio did not exceed 2.75 to 1.00 at September 30, 2022.
Material Changes and Unusual Items
- On November 1, 2022, after the quarter-end, DuPont terminated the merger agreement because regulatory approval from China’s SAMR had not been obtained. Rogers received a $162.5 million regulatory termination fee before taxes and transaction-related fees.
- Rogers incurred $18.3 million of expenses related to the terminated DuPont merger during the first nine months, including retention awards, the RESIP contribution, and professional services.
- The UTIS manufacturing facility fire in Ansan, South Korea continued to disrupt operations into the first half of 2023. For the first nine months, Rogers recognized $6.6 million of related insurance recoveries and incurred professional services, employee compensation, and other fire-related costs; the net impact was operating income of approximately $2.8 million.
- Foreign currency movements reduced nine-month sales by approximately $22.8 million and Q3 sales by approximately $11.8 million.
- Inventories rose 30.2% to $173.6 million, driven by higher raw-material costs and purchases and production intended to support anticipated demand.
- Accumulated other comprehensive loss increased to $125.4 million, primarily from an $80.4 million unfavorable foreign-currency translation adjustment for the first nine months.
Outlook, Risks, and Contingencies
- Management continued to target long-term revenue growth, stating that successful execution of its strategy could double annual revenue over five years, supported by advanced mobility, EV/HEV, ADAS, advanced connectivity, aerospace and defense, clean energy, and portable electronics.
- Management expected raw-material shortages, labor constraints, supply-chain disruptions, freight costs, and related margin pressure to continue into the fourth quarter of 2022. COVID-19 restrictions in China, semiconductor shortages, and the war in Ukraine were also affecting customers and suppliers.
- Key risks include foreign exchange, tariffs and U.S.-China trade restrictions, supplier concentration, inflationary costs, acquisition integration, technology and competition risks, covenant compliance, cybersecurity, and the ability to execute the standalone growth strategy following the terminated merger.
- Asbestos-related liabilities were $64.2 million and related insurance receivables were $58.9 million at September 30, 2022. There were 537 outstanding asbestos claims; settlements totaled approximately $1.7 million during the first nine months.
- The company had $0.8 million accrued for future remediation under the Connecticut VCAP environmental program. Management stated that known litigation and environmental matters were not expected to have a material adverse effect, but asbestos recoveries and liabilities remain subject to significant estimation uncertainty.
Investor Verification Points
- Verify the accounting, tax impact, and cash receipt timing of the $162.5 million DuPont termination fee.
- Assess whether gross-margin deterioration, working-capital usage, and low operating cash flow are temporary or structural.
- Review the company’s leverage and covenant headroom after the increase in revolving-credit borrowings.
- Monitor the UTIS facility recovery timetable, insurance proceeds, and potential remaining costs.
- Evaluate exposure to supply-chain disruption, raw-material and labor availability, semiconductor shortages, foreign exchange, and China-related restrictions.
- Review assumptions supporting asbestos liabilities and insurance receivables, including insurer solvency and future claim trends.